Literature DB >> 24001967

Biomarkers in the emergency workup of chest pain: uses, limitations, and future.

Wassim Mosleh1, Husam Abdel-Qadir, Michael Farkouh.   

Abstract

When patients present with chest pain, their levels of cardiac biomarkers are only one piece of the clinical picture, albeit an important one. Together with the history, physical examination, and electrocardiography (ECG), these levels help estimate the probability that the patient is experiencing an acute coronary syndrome and will have an adverse clinical outcome.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24001967     DOI: 10.3949/ccjm.80a.12112

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  3 in total

1.  Circulating miR-499 are novel and sensitive biomarker of acute myocardial infarction.

Authors:  Lizhu Zhang; Xi Chen; Tong Su; Heng Li; Qiang Huang; Dan Wu; Chengjian Yang; Zhijun Han
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

2.  Nutritional leucine supplementation attenuates cardiac failure in tumour-bearing cachectic animals.

Authors:  Aline Tatiane Toneto; Luiz Alberto Ferreira Ramos; Emilianne Miguel Salomão; Rebeka Tomasin; Miguel Arcanjo Aereas; Maria Cristina Cintra Gomes-Marcondes
Journal:  J Cachexia Sarcopenia Muscle       Date:  2016-02-24       Impact factor: 12.910

3.  Genome-wide DNA methylome alterations in acute coronary syndrome.

Authors:  Dandan Li; Jing Yan; Yunlong Yuan; Cheng Wang; Jia Wu; Qingwen Chen; Jiaxi Song; Junjun Wang
Journal:  Int J Mol Med       Date:  2017-10-27       Impact factor: 4.101

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.